Tablet vs. Troche vs. Lozenge: What's the Difference?

When a prescriber recommends ketamine tablet, one of the first questions patients have is about form: Will it be a tablet, a troche, or a lozenge? These terms are often used interchangeably in casual conversation, but they represent meaningfully different pharmaceutical formulations with distinct absorption profiles, clinical applications, and patient experiences.

Defining the Terms

What Is a Tablet?

A tablet is a solid, compressed dosage form designed to be swallowed whole. When you swallow a ketamine tablet, it travels to the stomach and small intestine where it dissolves and the drug is absorbed into the portal circulation. From there, it passes through the liver — the site of first-pass metabolism — before reaching systemic circulation.

Standard swallowed tablets have the lowest bioavailability among ketamine tablet forms, typically in the range of 10 to 20 percent. However, they offer precise, consistent dosing and are straightforward to manufacture and store.

What Is a Troche?

A troche (pronounced "TRO-kee") is a medicated lozenge designed to dissolve slowly in the mouth. The key distinction from a standard tablet is the intended route of absorption: troches are formulated to be held in the mouth, allowing the drug to absorb through the buccal mucosa (the inner lining of the cheeks) and sublingual mucosa (under the tongue).

Buccal and sublingual absorption bypass the first-pass hepatic metabolism that limits oral bioavailability, resulting in higher effective plasma levels — sometimes in the range of 25 to 35 percent bioavailability when used as intended. For practical guidance on administration technique, see how to take ketamine tablets.

Compounding pharmacies commonly prepare ketamine troches in fatty bases (such as cocoa butter or polyethylene glycol mixtures) that dissolve over 10 to 20 minutes. Some patients prefer to swallow the residual material after the troche has dissolved; others spit it out depending on their prescriber's protocol.

What Is a Lozenge?

The term "lozenge" is functionally interchangeable with "troche" in most clinical contexts. Both refer to medicated solid forms meant to dissolve in the mouth. However, lozenges sometimes refer specifically to hard candy-style preparations, while troches more often refer to softer, compounded preparations. In ketamine therapy, "lozenge" and "troche" are used interchangeably by most prescribers and pharmacies.

Spravato (esketamine), the FDA-approved intranasal ketamine product from Janssen, is distinct from all of these oral formulations — it is delivered via nasal spray and is not an oral form.

Absorption Differences

These numbers vary considerably between individuals based on genetics, gastric pH, food intake, and other factors.

Clinical Applications: When Is Each Used?

When Tablets Are Preferred

Tablets are favored in certain clinical scenarios:

• Maintenance therapy: Patients who have achieved a therapeutic response and need simple, consistent daily dosing often do well with tablets
• Pediatric and elderly patients: Tablets can be easier to handle for those who find the troche's dissolving process uncomfortable or confusing
• Chronic pain protocols: Low-dose daily tablet regimens are used in some pain management programs
• Compliance monitoring: The simplicity of swallowing a tablet makes adherence easier to track

Some clinicians prescribe low-dose oral tablets (e.g., 150 to 300 mg) for daily or twice-daily use in antidepressant augmentation protocols, where the goal is not acute dissociative effect but rather chronic glutamate modulation.

When Troches/Lozenges Are Preferred

Troches are preferred when:

• Higher bioavailability is desired: The buccal/sublingual component increases drug exposure without requiring higher doses
• Acute therapeutic sessions: Some protocols use troches for periodic "treatment sessions" rather than daily maintenance, aiming for a more pronounced effect
• Faster onset is beneficial: The sublingual component allows earlier peak onset compared to GI absorption alone
• At-home treatment: Many telehealth-based ketamine programs prescribe troches specifically because they can produce a mild therapeutic experience without requiring clinic-level monitoring at lower doses

Oral Solutions

Liquid ketamine tablet is sometimes used in:

• Pediatric patients who cannot swallow solid forms
• Palliative care settings requiring flexible titration
• Clinical research protocols requiring precise dose adjustment

Patient Experience Differences

From the patient's perspective, the experience of taking a troche versus swallowing a tablet can be quite different.

Troches require the patient to sit quietly for 15 to 20 minutes while the lozenge dissolves. Some patients find the taste unpleasant (ketamine has a bitter, somewhat chemical flavor that compounding pharmacies attempt to mask with flavorings). The gradual dissolution and buccal absorption means effects may begin while the troche is still dissolving.

Tablets require no special technique beyond swallowing. Effects take longer to appear — often 30 to 60 minutes — and the overall experience tends to be smoother and less intense at equivalent doses compared to troches, due to lower bioavailability and more gradual absorption.

Cost Considerations

Both tablets and troches are compounded products, meaning they are not covered by most insurance plans and are paid for out-of-pocket. Costs vary widely by pharmacy and region:

• Troches: Typically $15 to $30 per unit at a compounding pharmacy
• Tablets/capsules: Sometimes slightly less expensive per unit but depends heavily on the pharmacy

Patients should request itemized pricing from compounding pharmacies and compare options, as pricing can vary significantly between PCAB-accredited pharmacies.

What to Ask Your Prescriber

If you are being prescribed ketamine tablet, consider asking:

1. Which formulation are you prescribing, and why?
2. Should I hold the troche in my mouth, or swallow it?
3. Can I eat before taking it?
4. What is the goal — acute sessions, daily maintenance, or both?
5. How will we know if the formulation is working?

Understanding the distinctions between these formulations empowers patients to participate more actively in their own treatment decisions and to have more productive conversations with their prescribers.

References

• StatPearls: Ketamine — Comprehensive clinical reference on ketamine pharmacology, mechanisms of action, and therapeutic applications
• PubChem: Ketamine Compound Summary — NCBI chemical database entry with ketamine molecular data, pharmacokinetics, and bioactivity profiles
• MedlinePlus: Ketamine — National Library of Medicine consumer drug information on ketamine including uses, proper administration, and precautions
• Healthcare.gov: Understanding Costs — Federal marketplace resource explaining insurance terminology and out-of-pocket healthcare costs